ArticleRevista da Escola de Enfermagem da U S P2025
Prenatal tests in Brazil: prevalence and associated factors according to the Brazilian National Health Survey.
Article in Revista da Escola de Enfermagem da U S P, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- High Burden ofMicroorganisms · 2026Article
- Assessing progress towards the elimination of mother-to-child transmission of syphilis in Peru: A national retrospective analysis.PLOS global public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the prevalence of prenatal tests of pregnant women and factors associated with variation in this prevalence in the years of the Brazilian National Health Survey 2013 and 2019.
methodA cross-sectional study, carried out with women who underwent prenatal care, interviewed in the Brazilian National Health Survey 2013 (n = 1,851) and 2019 (n = 2,729).
resultsThe most prevalent tests were urine and blood, and the least prevalent were syphilis and HIV. During the period, the number of tests for syphilis (15.2; 95% CI: 11.0; 22.0) and HIV (4.3; 95% CI: 4.3; 8.0) increased, but the number of tests for the others decreased. The prevalence of tests for the four tests increased and reached 69.9% (95% CI: 67.0; 72.8) in 2019 compared to 60% (95% CI: 56.1; 63.9) in 2013.
conclusionThere was a greater number of prenatal tests performed, specifically for syphilis and HIV, rather than a reduction in the number of blood and urine tests. Despite the increase in access to all tests for the most vulnerable groups and locations in the country, prevalence in these groups is still low.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.